Leukemias are monoclonal diseases that arise from cells in the hematop
oietic stem and progenitor cell compartment. Consistent with emerging
models of carcinogenesis, leukemogenesis is an evolutionary process th
at involves multiple independent genetic and epigenetic events. Over t
he last half-century a predominant paradigm has emerged to describe le
ukemia developing secondary to alkylating drug therapy or exposure to
benzene in which progressive dysplastic changes, accompanied by a dist
inct pattern of clonal cytogenetic abnormalities, give rise to acute m
yelogenous leukemia. Characterization of these clonal chromosomal aber
rations, together with observed alterations in other growth-promoting
genes, provides a useful framework for studying chemical leukemogenesi
s and for use in understanding the origins and development of leukemia
in general.